Patent Property. Shall mean: (a) the U.S. PATENTS listed on Exhibit 1 and any and all continuations, continuations-in-part and divisions thereof; as well as any re-issuance and/or re-examination or any extension of the U.S. PATENTS listed on Exhibit 1; (b) the U.S. PATENT APPLICATIONS listed on Exhibit 1 and any and all continuations, continuations-in-part and divisions thereof; (c) any U.S. patents
... issuing on applications, continuations, continuations-in-part and divisions described in clause (b) of this paragraph; (d) any re-issuance and/or re-examination of the patents described in clause (c) of this paragraph; (e) the CORRESPONDING FOREIGN PATENTS AND APPLICATIONS listed on Exhibit 1 (and all continuations, continuations-in-part, divisions and any foreign equivalents thereof) and any foreign patents issuing on such applications, including any re-issuance, re-examination, and any foreign equivalents thereof; (f) any other U.S. or foreign patent applications and patents which claim as a priority date under 35 U.S.C. §119 or §120 one of the filing dates of, or priority dates claimed in, those U.S. PATENTS and U.S. PATENT APPLICATIONS listed on Exhibit 1; (g) the INVENTION DISCLOSURE listed on Exhibit 1, as well as any U.S. and foreign patent applications containing such disclosures (and all continuations, continuations-in-part and divisions thereof); (h) any U.S. and foreign patents issuing on applications, continuations, continuations-in-part, divisions and foreign equivalents thereof described in clauses (f) and (g), including any re-issued and/or re-examined patents and foreign equivalents based thereon; (i) all patents and inventions to which Coulter obtained rights and licenses pursuant to the Ortho Settlement Agreement; and (j) all patents and inventions to which Coulter obtained rights and licenses pursuant to the Dana-Farber License Agreements or any Additional Biotechnology Asset License Agreement (excluding any rights or licenses set forth in Section 1.12(i)).
View More
